Cabaletta Bio

Cabaletta Bio Presents Early Clinical Data From RESET-PV Trial Showing Rese-Cel Activity Without Preconditioning

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) presented initial data from its ongoing RESET-PV™ trial evaluating rese-cel (resecabtagene autoleucel, formerly CABA-201) in patients with pemphigus vulgaris (PV) during the …

Cabaletta Bio Presents Early Clinical Data From RESET-PV Trial Showing Rese-Cel Activity Without Preconditioning Read More



Vishay Intertechnology

Vishay Intertechnology Launches High-Reliability vPolyTan™ Capacitors for Aerospace and Defense Applications

MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) has introduced the DLA 04051 series of vPolyTan™ polymer surface-mount chip capacitors, developed to meet the stringent demands of aerospace, military, and …

Vishay Intertechnology Launches High-Reliability vPolyTan™ Capacitors for Aerospace and Defense Applications Read More